The recurrent involvement of the miR-17-92 cluster as pathological signature in lymphoma cell lines and tissues suggests that the key factor in determining the miRNA signatures could be linked to MYC action [18, 22, 25, 47, 48]. Here, MYC is linked to lymphoma.